{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:41:09Z","timestamp":1792806069720,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Drug Discov"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1038\/nrd2199","type":"journal-article","created":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T05:24:31Z","timestamp":1164950671000},"page":"993-996","source":"Crossref","is-referenced-by-count":3244,"title":["How many drug targets are there?"],"prefix":"10.1038","volume":"5","author":[{"given":"John P.","family":"Overington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bissan","family":"Al-Lazikani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrd2199_CR1","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1038\/nbt1196-1516","volume":"14","author":"J Drews","year":"1996","unstructured":"Drews, J. Genomic sciences and the medicine of tomorrow. Nature Biotechnol. 14, 1516\u20131518 (1996).","journal-title":"Nature Biotechnol."},{"key":"BFnrd2199_CR2","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/nbt1297-1318","volume":"15","author":"J Drews","year":"1997","unstructured":"Drews, J. & Ryser, S. Classic drug targets. Nature Biotechnol. 15, 1318\u20131319 (1997).","journal-title":"Nature Biotechnol."},{"key":"BFnrd2199_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Del. Rev. 23, 3\u201325 (1997).","journal-title":"Adv. Drug Del. Rev."},{"key":"BFnrd2199_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrd892","volume":"1","author":"AL Hopkins","year":"2002","unstructured":"Hopkins, A. L. & Groom, C. R. The druggable genome. Nature Rev. Drug Discov. 1, 727\u2013730 (2002).","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnrd2199_CR5","first-page":"310","volume":"6","author":"JB Golden","year":"2003","unstructured":"Golden, J. B. Prioritizing the human genome: knowledge management for drug discovery. Curr. Opin. Drug Discov. Dev. 6, 310\u2013316 (2003).","journal-title":"Curr. Opin. Drug Discov. Dev."},{"key":"BFnrd2199_CR6","unstructured":"Golden, J. Towards a tractable genome: knowledge management in drug discovery. Curr. Drug Discov. 17\u201320 (2003)."},{"key":"BFnrd2199_CR7","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"43","author":"DS Wishart","year":"2006","unstructured":"Wishart, D. S. et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 43, D668\u2013D672 (2006).","journal-title":"Nucleic Acids Res."},{"key":"BFnrd2199_CR8","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/nrd2132","volume":"5","author":"P Imming","year":"2006","unstructured":"Imming, P., Sinning, C. & Meyer, A. Drugs, their targets and the nature and number of drug targets. Nature Rev. Drug Discov. 5, 821\u2013834 (2006).","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnrd2199_CR9","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.drudis.2006.03.012","volume":"11","author":"C Zheng","year":"2006","unstructured":"Zheng, C., Han, L., Yap, C. W., Xie, B. & Chen, Y. Progress and problems in the exploration of therapeutic targets. Drug Discov. Today 11, 412\u2013420 (2006).","journal-title":"Drug Discov. Today"},{"key":"BFnrd2199_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1124\/pr.58.2.4","volume":"58","author":"CJ Zheng","year":"2006","unstructured":"Zheng, C. J. et al. Therapeutic targets: progress of their explorations and investigation of their characteristics. Pharma. Rev. 58, 259\u2013279 (2006).","journal-title":"Pharma. Rev."},{"key":"BFnrd2199_CR11","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nm0596-561","volume":"2","author":"BJ Druker","year":"1996","unstructured":"Druker, B. J. et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nature Med. 2, 561\u2013566 (1996).","journal-title":"Nature Med."},{"key":"BFnrd2199_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nbt1068","volume":"23","author":"MA Fabian","year":"2005","unstructured":"Fabian, M. A. et al. A small molecule-kinase interaction map for clinical kinase inhibitors. Nature Biotechnol. 23, 329\u2013336 (2005).","journal-title":"Nature Biotechnol."},{"key":"BFnrd2199_CR13","doi-asserted-by":"publisher","first-page":"55827","DOI":"10.1074\/jbc.M409792200","volume":"279","author":"S Atwell","year":"2004","unstructured":"Atwell, S. et al. A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase. J. Biol. Chem. 279, 55827\u201355832 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2199_CR14","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V96.3.925","volume":"96","author":"MC Heinrich","year":"2000","unstructured":"Heinrich, M. C. et al. Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood 96, 925\u2013932 (2000).","journal-title":"Blood"},{"key":"BFnrd2199_CR15","doi-asserted-by":"publisher","first-page":"6388S","DOI":"10.1158\/1078-0432.CCR-040028","volume":"10","author":"T Ahmad","year":"2004","unstructured":"Ahmad, T. & Eisen, T. Kinase inhibition with BAY 43\u20139006 in renal cell carcinoma. Clin. Cancer Res. 10, 6388S\u20136392S (2004).","journal-title":"Clin. Cancer Res."},{"key":"BFnrd2199_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1021\/jm030912m","volume":"47","author":"A Weber","year":"2004","unstructured":"Weber, A. et al. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: New pharmacological opportunities due to related binding site recognition. J. Med. Chem. 47, 550\u2013557 (2004).","journal-title":"J. Med. Chem."},{"key":"BFnrd2199_CR17","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nbt1228","volume":"24","author":"GV Paolini","year":"2006","unstructured":"Paolini, G. V., Shapland, R. H. B., van Hoorn, W. P., Mason, J. S. & Hopkins, A. L. Global mapping of pharmacological space. Nature Biotechnol. 24, 805\u2013815 (2006).","journal-title":"Nature Biotechnol."},{"key":"BFnrd2199_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.sbi.2006.01.013","volume":"16","author":"AL Hopkins","year":"2006","unstructured":"Hopkins, A. L., Mason, J. S. & Overington, J. P. Can we rationally design promiscuous drugs?. Curr. Opin. Struct. Biol. 16, 127\u2013136 (2006).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"BFnrd2199_CR19","first-page":"536","volume":"274","author":"AG Murzin","year":"1995","unstructured":"Murzin, A. G., Brenner, S. E., Hubbard, T. & Chothia, C. SCOP: a structural classification of proteins database for the investigation of sequences and structures. J. Mol. Biol. 274, 536\u2013540 (1995).","journal-title":"J. Mol. Biol."},{"key":"BFnrd2199_CR20","doi-asserted-by":"publisher","first-page":"D138","DOI":"10.1093\/nar\/gkh121","volume":"32","author":"A Bateman","year":"2004","unstructured":"Bateman, A. et al. The Pfam Protein Families Database. Nucleic Acids Res. 32, D138\u2013D141 (2004).","journal-title":"Nucleic Acids Res."},{"key":"BFnrd2199_CR21","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nature01256","volume":"420","author":"EV Koonin","year":"2002","unstructured":"Koonin, E. V., Wolf, Y. I. & Karev, G. P. The structure of the protein universe and genome evolution. Nature 420, 218\u2013223 (2002).","journal-title":"Nature"},{"key":"BFnrd2199_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/88640","volume":"8","author":"D Vitkup","year":"2001","unstructured":"Vitkup, D., Melamud, E., Moult, J. & Sander, C. Completeness in structural genomics. Nature Struct. Biol. 8, 559\u2013566 (2001).","journal-title":"Nature Struct. Biol."},{"key":"BFnrd2199_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M. et al. The Protein Data Bank. Nucleic Acid Res. 28, 235\u2013242 (2000).","journal-title":"Nucleic Acid Res."},{"key":"BFnrd2199_CR24","doi-asserted-by":"crossref","DOI":"10.56021\/9780801857423","volume-title":"Mendelian Inheritance in Man","author":"VA McKusick","year":"1998","unstructured":"McKusick, V. A. in Mendelian Inheritance in Man 12th Edn (John Hopkins University Press, Baltimore, 1998)."},{"key":"BFnrd2199_CR25","unstructured":"NIHCM 24 pp (National Institute for Health Care Management Research and Educational Foundation, 2002)."},{"key":"BFnrd2199_CR26","volume-title":"The Innovator's Dilemma: When New Technologies Cause Great Firms to Fail","author":"CM Christensen","year":"1997","unstructured":"Christensen, C. M. The Innovator's Dilemma: When New Technologies Cause Great Firms to Fail (Harvard Business School Press, Cambridge, 1997)."},{"key":"BFnrd2199_CR27","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/S0140-6736(05)74775-9","volume":"355","author":"TN Raju","year":"2000","unstructured":"Raju, T. N. The Nobel chronicles. Lancet 355, 1022 (2000).","journal-title":"Lancet"}],"container-title":["Nature Reviews Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrd2199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrd2199","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrd2199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T12:14:36Z","timestamp":1707394476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrd2199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["BFnrd2199"],"URL":"https:\/\/doi.org\/10.1038\/nrd2199","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1052888.504824","asserted-by":"object"}]},"ISSN":["1474-1776","1474-1784"],"issn-type":[{"value":"1474-1776","type":"print"},{"value":"1474-1784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}